Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'ESRD' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 246 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Fabrizi, F; Martin, P; Lunghi, G; Locatelli, F
      TT virus infection in end-stage renal disease (ESRD)

      JOURNAL OF NEPHROLOGY
    2. Mohr, PE
      The economics of daily dialysis

      ADVANCES IN RENAL REPLACEMENT THERAPY
    3. Nissenson, AR
      Daily hemodialysis: Challenges and opportunities in the delivery and financing of end-stage renal disease patient care

      ADVANCES IN RENAL REPLACEMENT THERAPY
    4. Furth, SL; Gerson, AC; Neu, AM; Fivush, BA
      The impact of dialysis and transplantation on children

      ADVANCES IN RENAL REPLACEMENT THERAPY
    5. Langman, CB
      The optimal approach to the patient with oxalosis

      ADVANCES IN RENAL REPLACEMENT THERAPY
    6. Krisher, J; Pastan, S
      Promoting quality of care for ESRD patients: The role of the ESRD networks

      ADVANCES IN RENAL REPLACEMENT THERAPY
    7. Bommer, J
      Attaining long-term survival when treating diabetic patients with ESRD by hemodialysis

      ADVANCES IN RENAL REPLACEMENT THERAPY
    8. Passadakis, P; Oreopoulos, D
      Peritoneal dialysis in diabetic patients

      ADVANCES IN RENAL REPLACEMENT THERAPY
    9. Mehrotra, R; Nolph, KD
      Peritoneal dialysis should be the first choice of initial renal replacement therapy for more patients with end-stage renal disease

      ASAIO JOURNAL
    10. Enia, G; Mallamaci, F; Benedetto, FA; Panuccio, V; Parlongo, S; Cutrupi, S; Giacone, G; Cottini, E; Tripepi, G; Malatino, LS; Zoccali, C
      Long-term CAPD patients are volume expanded and display more severe left ventricular hypertrophy than haemodialysis patients

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    11. Jungers, P; Massy, ZA; Nguyen-Khoa, T; Choukroun, G; Robino, C; Fakhouri, F; Touam, M; Nguyen, AT; Grunfeld, JP
      Longer duration of predialysis nephrological care is associated with improved long-term survival of dialysis patients

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    12. Blake, PG
      Integrated end-stage renal disease care: the role of peritoneal dialysis

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    13. Epstein, M
      Aldosterone as a mediator of progressive renal dysfunction: Evolving perspectives

      INTERNAL MEDICINE
    14. Holley, JL; Aslam, N; Bernardini, J; Fried, L; Piraino, B
      The influence of demographic factors and modality on loss of residual renal function in incident peritoneal dialysis patients

      PERITONEAL DIALYSIS INTERNATIONAL
    15. Blake, PG; Finkelstein, FO
      Why is the proportion of patients doing peritoneal dialysis declining in North America?

      PERITONEAL DIALYSIS INTERNATIONAL
    16. Ludemann, P; Zwernemann, S; Lerchl, A
      Clearance of melatonin and 6-sulfatoxymelatonin by hemodialysis in patients with end-stage renal disease

      JOURNAL OF PINEAL RESEARCH
    17. Jager, KJ; Merkus, MP; Boeschoten, EW; Dekker, FW; Tijssen, JGP; Krediet, RT
      What happens to patients starting dialysis in The Netherlands?

      NETHERLANDS JOURNAL OF MEDICINE
    18. Iseki, K; Wakugami, K; Maehara, A; Tozawa, M; Muratani, H; Fukiyama, K
      Evidence for high incidence of end-stage renal disease in patients after stroke and acute myocardial infarction at age 60 or younger

      AMERICAN JOURNAL OF KIDNEY DISEASES
    19. Hebert, MJ; Masse, M; Vigneault, N; Sirois, I; Troyanov, S; Madore, F
      Soluble fas is a marker of coronary artery disease in patients with end-stage renal disease

      AMERICAN JOURNAL OF KIDNEY DISEASES
    20. Sprague, SM; Lerma, E; McCormmick, D; Abraham, M; Batlle, D
      Suppression of parathyroid hormone secretion in hemodialysis patients: Comparison of paricalcitol with calcitriol

      AMERICAN JOURNAL OF KIDNEY DISEASES
    21. Martin, KJ; Gonzalez, E; Lindberg, JS; Taccetta, C; Amdahl, M; Malhotra, K; Llach, F
      Paricalcitol dosing according to body weight or severity of hyperparathyroidism: A double-blind, multicenter, randomized study

      AMERICAN JOURNAL OF KIDNEY DISEASES
    22. Stack, AG; Bloembergen, WE
      A cross-sectional study of the prevalence and clinical correlates of congestive heart failure among incident US dialysis patients

      AMERICAN JOURNAL OF KIDNEY DISEASES
    23. Hellstrom, L; Elinder, CG; Dahlberg, B; Lundberg, M; Jarup, L; Persson, B; Axelson, O
      Cadmium exposure and end-stage renal disease

      AMERICAN JOURNAL OF KIDNEY DISEASES
    24. McLaughlin, K; Manns, B; Culleton, B; Donaldson, C; Taub, K
      An economic evaluation of early versus late referral of patients with progressive renal insufficiency

      AMERICAN JOURNAL OF KIDNEY DISEASES
    25. Perazella, MA
      Pharmacologic options available to treat symptomatic intradialytic hypotension

      AMERICAN JOURNAL OF KIDNEY DISEASES
    26. Collins, AJ; Li, SL; Ma, JZ; Herzog, C
      Cardiovascular disease in end-stage renal disease patients

      AMERICAN JOURNAL OF KIDNEY DISEASES
    27. Shoji, T; Ishimura, E; Inaba, M; Tabata, T; Nishizawa, Y
      Atherogenic lipoproteins in end-stage renal disease

      AMERICAN JOURNAL OF KIDNEY DISEASES
    28. Akmal, M
      Hemodialysis in diabetic patients

      AMERICAN JOURNAL OF KIDNEY DISEASES
    29. Lewis, J; Agodoa, L; Cheek, D; Greene, T; Middleton, J; O'Connor, D; Ojo, A; Phillips, R; Sika, M; Wright, J
      Comparison of cross-sectional renal function measurements in African Americans with hypertensive nephrosclerosis and of primary formulas to estimate glomerular filtration rate

      AMERICAN JOURNAL OF KIDNEY DISEASES
    30. Valderrabano, F; Jofre, R; Lopez-Gomez, JM
      Quality of life in end-stage renal disease patients

      AMERICAN JOURNAL OF KIDNEY DISEASES
    31. Ifudu, O; Uribarri, J; Rajwani, I; Vlacich, V; Reydel, K; Delosreyes, G; Friedman, EA
      Gender modulates responsiveness to recombinant erythropoietin

      AMERICAN JOURNAL OF KIDNEY DISEASES
    32. Norris, KC; Thornhill-Joynes, M; Robinson, C; Strickland, T; Alperson, BL; Witana, SC; Ward, HJ
      Cocaine use, hypertension, and end-stage renal disease

      AMERICAN JOURNAL OF KIDNEY DISEASES
    33. Watson, B; Khan, MA; Desmond, RA; Bergman, S
      Mitochondrial DNA mutations in black Americans with hypertension-associated end-stage renal disease

      AMERICAN JOURNAL OF KIDNEY DISEASES
    34. Freedman, BI; Soucie, JM; Kenderes, B; Krisher, J; Garrett, LE; Caruana, RJ; McClellan, WM
      Family history of end-stage renal disease does not predict dialytic survival

      AMERICAN JOURNAL OF KIDNEY DISEASES
    35. Perneger, TV; Klag, MJ; Whelton, PK
      Recreational drug use: A neglected risk factor for end-stage renal disease

      AMERICAN JOURNAL OF KIDNEY DISEASES
    36. Reddan, DN; Marcus, RJ; Owen, WF; Szczech, LA; Landwehr, DM
      Long-term outcomes of revascularization for peripheral vascular disease inend-stage renal disease patients

      AMERICAN JOURNAL OF KIDNEY DISEASES
    37. Fatica, RA; Port, FK; Young, EW
      Incidence trends and mortality in end-stage renal disease attributed to renovascular disease in the United States

      AMERICAN JOURNAL OF KIDNEY DISEASES
    38. Nissenson, AR; Collins, AJ; Dickmeyer, J; Litchfield, T; Mattern, W; McMahill, CN; Muhlbaier, L; Nielsen, J; Owen, WF; Pereira, BJG; Steinman, TI; Szczech, L
      Evaluation of disease-state management of dialysis patients

      AMERICAN JOURNAL OF KIDNEY DISEASES
    39. Brass, EP; Adler, S; Sietsema, KE; Hiatt, WR; Orlando, AM; Amato, A
      Intravenous L-carnitine increases plasma carnitine, reduces fatigue, and may preserve exercise capacity in hemodialysis patients

      AMERICAN JOURNAL OF KIDNEY DISEASES
    40. Epstein, M
      Aldosterone as a mediator of progressive renal disease: Pathogenetic and clinical implications

      AMERICAN JOURNAL OF KIDNEY DISEASES
    41. Fletes, R; Lazarus, JM; Gage, J; Chertow, GM
      Suspected iron dextran-related adverse drug events in hemodialysis patients

      AMERICAN JOURNAL OF KIDNEY DISEASES
    42. Wilmer, WA; Voroshilova, O; Singh, I; Middendorf, DF; Cosio, FG
      Transcutaneous oxygen tension in patients with calciphylaxis

      AMERICAN JOURNAL OF KIDNEY DISEASES
    43. Covic, AMC; Iyengar, SK; Olson, JM; Sehgal, AR; Constantiner, M; Jedrey, C; Kara, M; Sabbagh, E; Sedor, JR; Schelling, JR
      A family-based strategy to identify genes for diabetic nephropathy

      AMERICAN JOURNAL OF KIDNEY DISEASES
    44. Winkelmayer, WC; Eigner, M; Berger, O; Grisold, W; Leithner, C
      Optic neuropathy in uremia: An interdisciplinary emergency

      AMERICAN JOURNAL OF KIDNEY DISEASES
    45. Silang, R; Regalado, M; Cheng, TH; Wesson, DE
      Prokinetic agents increase plasma albumin in hypoalbuminemic chronic dialysis patients with delayed gastric emptying

      AMERICAN JOURNAL OF KIDNEY DISEASES
    46. Alexander, GC; Sehgal, AR
      Why hemodialysis patients fail to complete the transplantation process

      AMERICAN JOURNAL OF KIDNEY DISEASES
    47. Fried, L; Bernardini, J; Piraino, B
      Charlson comorbidity index as a predictor of outcomes in incident peritoneal dialysis patients

      AMERICAN JOURNAL OF KIDNEY DISEASES
    48. Kim, SB; Lee, SK; Park, JS; Chi, HS; Hong, CD; Yang, WS
      Effects of fixed low-dose warfarin on hemostatic factors in continuous ambulatory peritoneal dialysis patients

      AMERICAN JOURNAL OF KIDNEY DISEASES
    49. Keane, WF; Brenner, BM; Mazzu, A; Agro, A
      The CHORUS (Cerivastatin in heart outcomes in renal disease Understanding survival) protocol: A double-blind, placebo-controlled trial in patients with ESRD

      AMERICAN JOURNAL OF KIDNEY DISEASES
    50. Mendelssohn, DC; Mullaney, SR; Jung, B; Blake, PG; Mehta, RL
      What do American nephrologists think about dialysis modality selection?

      AMERICAN JOURNAL OF KIDNEY DISEASES
    51. Konoshita, T; Miyagi, K; Onoe, T; Katano, K; Mutoh, H; Nomura, H; Koni, I; Miyamori, I; Mabuchi, H
      Effect of ACE gene polymorphism on age at renal death in polycystic kidneydisease in Japan

      AMERICAN JOURNAL OF KIDNEY DISEASES
    52. Levine, DZ
      Divided loyalties: Relationships between nephrologists and industry

      AMERICAN JOURNAL OF KIDNEY DISEASES
    53. Epstein, M
      Aldosterone and the hypertensive kidney: its emerging role as a mediator of progressive renal dysfunction: a paradigm shift

      JOURNAL OF HYPERTENSION
    54. Keshaviah, P
      Resource limitations and strategies for the treatment of uremia - A dialysis unit in the Himalayan foothills

      BLOOD PURIFICATION
    55. de Francisco, ALM; Arias, M
      Survival markers in dialysis

      NEFROLOGIA
    56. Parving, HH; Harrington, JT; Lewis, J; Boner, G; Lewis, EJ; Viberti, G; Gilbert, R; Raz, I; Cooper, M; Rossing, K
      Diabetic nephropathy: Prevention and treatment

      KIDNEY INTERNATIONAL
    57. Tokars, JI; Gehr, T; Jarvis, WR; Anderson, J; Armistead, N; Miller, ER; Parrish, J; Qaiyumi, S; Arduino, M; Holt, SC; Tenover, FC; Westbrook, G; Light, P
      Vancomycin-resistant enterococci colonization in patients at seven hemodialysis centers

      KIDNEY INTERNATIONAL
    58. Morris, STW; McMurray, JJV; Spiers, A; Jardine, AG
      Impaired endothelial function in isolated human uremic resistance arteries

      KIDNEY INTERNATIONAL
    59. Johansen, KL; Painter, P; Kent-Braun, JA; Ng, AV; Carey, S; Da Silva, M; Chertow, GM
      Validation of questionnaires to estimate physical activity and functioningin end-stage renal disease

      KIDNEY INTERNATIONAL
    60. Reimer, J; Franke, GH; Luetkes, P; Kohnle, M; Philipp, T; Heemann, U
      Quality of life after kidney transplantation - The impact of tacrolimus

      TRANSPLANTATION PROCEEDINGS
    61. Zeisberg, M; Strutz, F; Muller, GA
      Role of fibroblast activation in inducing interstitial fibrosis

      JOURNAL OF NEPHROLOGY
    62. Palevsky, PM; Washington, MS; Stevenson, JA; Rohay, JM; Dyer, NJ; Lockett, R; Perry, SB
      Barriers to the delivery of adequate hemodialysis in ESRD Network 4

      ADVANCES IN RENAL REPLACEMENT THERAPY
    63. Palevsky, PM; Washington, MS; Stevenson, JA; Rohay, JM; Dyer, NJ; Lockett, R; Perry, SB
      Improving compliance with the dialysis prescription as a strategy to increase the delivered dose of hemodialysis: An ESRD Network 4 quality improvement project

      ADVANCES IN RENAL REPLACEMENT THERAPY
    64. Armistead, N; Mays, C
      1999 Facility Profile Reports

      ADVANCES IN RENAL REPLACEMENT THERAPY
    65. Rosenblum, AJ; Harbert, G; Knotek, B; Husni, L
      Mission possible: Vascular access - Decreasing the use of catheters in thetexas hemodialysis community

      ADVANCES IN RENAL REPLACEMENT THERAPY
    66. Rodgers, DJ; Karp, SK; Woodruff, SD; Wright, LD; Stiles, SK
      Influenza immunization rates in the Intermountain End-Stage Renal Disease Network (Network 15)

      ADVANCES IN RENAL REPLACEMENT THERAPY
    67. Diamond, LH
      Patient safety: The challenges and opportunities for the ESRD Program

      ADVANCES IN RENAL REPLACEMENT THERAPY
    68. Beck, LH
      Screening and preventive health practices for the end-stage renal disease patient

      ADVANCES IN RENAL REPLACEMENT THERAPY
    69. Calder, AE; Banning, J
      The ECB Renal Patient Questionnaire: An assessment tool to determine renalpatients' needs for immediate social work intervention

      ADVANCES IN RENAL REPLACEMENT THERAPY
    70. Khan, MA; Collins, AJ; Keane, WF
      Diabetes in the elderly population

      ADVANCES IN RENAL REPLACEMENT THERAPY
    71. Arthur, T; Zalemski, S; Giermek, D; Lamb, C
      Educating community providers changes beliefs towards caring for the ESRD patient

      ADVANCES IN RENAL REPLACEMENT THERAPY
    72. Hallegua, D; Wallace, DJ; Metzger, AL; Rinaldi, RZ; Klinenberg, JR
      Cyclosporine for lupus membranous nephritis: experience with ten patients and review of the literature

      LUPUS
    73. Ledebo, I; Lameire, N; Charra, B; Locatelli, F; Kooistra, M; Kessler, M; Jacobs, C
      Improving the outcome of dialysis - opinion vs scientific evidence - Report on the Dialysis Opinion Symposium at the ERA-EDTA Congress, 6 September 1999, Madrid

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    74. Diaz-Buxo, JA
      Early referral and selection of peritoneal dialysis as a treatment modality

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    75. Rutkowski, B
      Changing pattern of end-stage renal disease in central and eastern Europe

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    76. Jungers, P; Choukroun, G; Robino, C; Massy, ZA; Taupin, P; Labrunie, M; Man, NK; Landais, P
      Epidemiology of end-stage renal disease in the Ile-de-France area: a prospective study in 1998

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    77. Zarif, L; Covic, A; Iyengar, S; Sehgal, AR; Sedor, JR; Schelling, JR
      Inaccuracy of clinical phenotyping parameters for hypertensive nephrosclerosis

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    78. Locatelli, F; Di Filippo, S; Manzoni, C
      Removal of small and middle molecules by convective techniques

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    79. Sarnak, MJ; Levey, AS
      Epidemiology, diagnosis, and management of cardiac disease in chronic renal disease

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    80. Johnson, DW; Herzig, KA; Purdie, DM; Chang, W; Brown, AM; Rigby, RJ; Campbell, SB; Nicol, DL; Hawley, CM
      Is obesity a favorable prognostic factor in peritoneal dialysis patients?

      PERITONEAL DIALYSIS INTERNATIONAL
    81. Conlon, PJ; Kovalik, E; Schumm, D; Minda, S; Schwab, SJ
      Normalization of hematocrit in hemodialysis patients with cardiac disease does not increase blood pressure

      RENAL FAILURE
    82. Gerdemann, A; Lemke, HD; Nothdurft, A; Heidland, A; Munch, G; Bahner, U; Schinzel, R
      Low-molecular but not high-molecular advanced glycation end products (AGEs) are removed by high-flux dialysis

      CLINICAL NEPHROLOGY
    83. Diop, ME; Viron, B; Bailleul, S; Lefevre, G; Fessi, H; Maury, J; Etienne, J; Couderc, R
      Lp(a) is increased in hemodialysis patients according to the type of dialysis membrane: a 2-year follow-up study

      CLINICAL NEPHROLOGY
    84. Kuhlmann, U; Becker, HF; Birkhahn, M; Peter, JH; von Wichert, P; Schutterle, S; Lange, H
      Sleep-apnea in patients with end-stage renal disease and objective results

      CLINICAL NEPHROLOGY
    85. Franke, GH; Reimer, J; Lutkes, P; Kohnle, M; Gerken, G; Philipp, T; Heemann, U
      Presentation of a psychodiagnostic inventory measuring disease-specific quality of life in kidney transplant recipients

      NIEREN-UND HOCHDRUCKKRANKHEITEN
    86. Sattler, G; Brass, H; Uppenkamp, M
      Prolongation of the dosing interval of rhEPO - influence on the effectiveness in patients on hemodialysis?

      NIEREN-UND HOCHDRUCKKRANKHEITEN
    87. Kao, CH; Hsieh, JF; Tsai, SC; Ho, YJ; Chang, HR
      Decreased salivary function in patients with end-stage renal disease requiring hemodialysis

      AMERICAN JOURNAL OF KIDNEY DISEASES
    88. Thamer, M; Hwang, WK; Fink, NE; Sadler, JH; Wills, S; Levin, NW; Bass, EB; Levey, AS; Brookmeyer, R; Powe, NR
      US nephrologists' recommendation of dialysis modality: Results of a national survey

      AMERICAN JOURNAL OF KIDNEY DISEASES
    89. Ifudu, O; Uribarri, J; Rajwani, I; Vlacich, V; Reydel, K; Delosreyes, G; Friedman, EA
      Adequacy of dialysis and differences in hematocrit among dialysis facilities

      AMERICAN JOURNAL OF KIDNEY DISEASES
    90. Alcazar, JM; Rodicio, JL
      Ischemic nephropathy: Clinical characteristics and treatment

      AMERICAN JOURNAL OF KIDNEY DISEASES
    91. Wolfe, RA; Ashby, VB; Milford, EL; Bloembergen, WE; Agodoa, LYC; Held, PJ; Port, FK
      Differences in access to cadaveric renal transplantation in the United States

      AMERICAN JOURNAL OF KIDNEY DISEASES
    92. Dahdah, K; Patrie, JT; Bolton, WK
      Intravenous iron dextran treatment in predialysis patients with chronic renal failure

      AMERICAN JOURNAL OF KIDNEY DISEASES
    93. Schrier, RW
      Treating high-risk diabetic hypertensive patients with comorbid conditions

      AMERICAN JOURNAL OF KIDNEY DISEASES
    94. Ward, MM
      Cardiovascular and cerebrovascular morbidity and mortality among women with end-stage renal disease attributable to lupus nephritis

      AMERICAN JOURNAL OF KIDNEY DISEASES
    95. Ahuja, TS; Borucki, M; Grady, J
      Highly active antiretroviral therapy improves survival of HIV-infected hemodialysis patients

      AMERICAN JOURNAL OF KIDNEY DISEASES
    96. Fernandes, PF; Ellis, PA; Roderick, PJ; Cairns, HS; Hicks, JA; Cameron, JS
      Causes of end-stage renal failure in black patients starting renal replacement therapy

      AMERICAN JOURNAL OF KIDNEY DISEASES
    97. Brem, AS; Lambert, C; Hill, C; Kitsen, J; Shemin, DG
      Outcome data on pediatric dialysis patients from the End-Stage Renal Disease Clinical Indicators Project

      AMERICAN JOURNAL OF KIDNEY DISEASES
    98. Frankenfield, DL; Sugarman, JR; Presley, RJ; Helgerson, SD; Rocco, MV
      Impact of facility size and profit status on intermediate outcomes in chronic dialysis patients

      AMERICAN JOURNAL OF KIDNEY DISEASES
    99. Cagney, KA; Wu, AW; Fink, NE; Jenckes, MW; Meyer, KB; Bass, EB; Powe, NR
      Formal literature review of quality-of-life instruments used in end-stage renal disease

      AMERICAN JOURNAL OF KIDNEY DISEASES
    100. Casserly, LF; Reddy, SM; Dember, LM
      Venous thromboembolism in end-stage renal disease

      AMERICAN JOURNAL OF KIDNEY DISEASES


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 22/10/20 alle ore 21:37:08